In total, 48% of all participants who were on non-insulin treatment and 91% of Belgians (Figure 1, Chart 9), for whom T2DM had lasted ∼1.6 years (Table 1), expressed anxiety about insulin use. This evidence concerns the gene INS and type 2 diabetes mellitus.